OFEV is contraindicated in patients with known hypersensitivity to nintedanib, peanut or soya, or to any of the excipients (see Description).
OFEV is contraindicated during pregnancy (see Use in Pregnancy & Lactation and Pharmacology: Toxicology under Actions).
NSCLC: For contraindications of docetaxel refer to the corresponding product information for docetaxel.